Dry eye is a very common condition in many parts of the world. Both ophthalmologists and other healthcare professionals, such as optometrists and general practitioners, are often involved in the care of these patients. The main thrust of dry eye management is over-the-counter tear lubricants. There is a wide range of tear lubricants available today. These lubricants vary in viscosity, duration of action, type of preservatives, osmolarity/osmolality and pH. This article aims to educate healthcare professionals on 1) how to assess and manage patients with mild to moderate dry eyes and 2) how to identify patients who may need a referral to an ophthalmologist. Strategies on the use of available treatments and their limitations, as well as factors that may affect patient compliance will be discussed.
INtrODUctION
Dry eye disease (DED) is a multi-factorial disease that affects the tears and ocular surface. It is associated with symptoms of discomfort, visual disturbance and abnormal tear film from either tear deficiency or excessive tear evaporation 1 . Significant ocular surface damage is common in patients with dry eye 2 . Dry eye disease has been shown to adversely impact the quality of life of patients by interfering with daily activities, such as navigating stairs, recognising friends, reading, driving and so forth 3 . Dry eye disease affects millions of people around the world with prevalence rates estimated to be as high as 35% in the general population 1, [4] [5] [6] . This high prevalence makes it very likely that these patients will seek advice not only from an ophthalmologist, but also from other healthcare professionals such as general practitioners and optometrists.
This article aims to educate healthcare professionals on 1) how to assess and manage patients with mild to moderate dry eye and 2) how to identify patients who need a referral to an ophthalmologist. Available treatments and their limitations, as well as factors that may affect patient compliance will also be discussed.
Patient Assessment
A patient with dry eye may approach an optometrist or general practitioner with complaints about discomfort of the eyes. Symptoms may include dryness, redness, heaviness of the eyelids, blurry vision, discomfort in air conditioned places and tiredness after long hours spent performing visual tasks (such as reading, watching TV, computer work, etc). In some cases, the patient may also mention watery eyes. Paradoxically, the presence of watery eyes may be an indication of dry eye as it may be 9 . Patients with systemic autoimmune diseases, for instance Sjögren's syndrome, are also associated with the more severe type of dry eye 10 and systemic immune suppression may be necessary. Patients with thyroid disease may have lid abnormalities such as lagophthalmos and orbital pathology which result in exophthalmos 11 .
Commonly used tools for diagnosis of dry eye include Schirmer's test strips for an evaluation of tear production and fluorescein dye for assessment of corneal epithelial defects and tear film breakup time 1 . The Schirmer's test, when used alone, may not be effective as results do not correlate well to dry eye symptoms 12 . In fact, patients with dry eye may have a falsely high or normal reading due to the irritation caused by the filter strip and subsequent reflex tearing.
Fluorescein dye is very helpful and is available in disposable strips and used in combination with sterile saline. A biomicroscope or light source fitted with a cobalt-blue light filter may then reveal bright green dots (staining) indicating corneal epithelial defects 13 . Additionally, the dye can be used to approximate the tear film break-up time as an indicator for tear film stability. Eyelid inflammation 14 or a condition called meibomian gland dysfunction (MGD) 15 may also be observed. Tear stability and lid examination techniques, however, may require magnification from a biomicroscope that is often not available in general medical practice. Tear instability or associated lid disease may be improved with warm compresses using hot towels or microwavable eye masks and eyelid hygiene 16 .
Testing of corneal sensation with a cotton wisp to exclude hypoesthetic or anaesthetic corneas is a critical step, because patients with a significantly decreased sensitivity carry a higher risk of developing neurotrophic ulceration and should be referred to ophthalmologists 17 . Pterygium, a fleshy fibrovascular tissue that grows centripetally from the conjunctiva to the cornea, is often associated with reduced tear stability 18 . These patients should be referred to an ophthalmologist for surgical excision if vision is affected 19 .
Since dry eye is multi-factorial 1 , the patient's lifestyle and environmental factors that may contribute to dry eye symptoms should be elicited. This includes assessment of contact lens wear 20 and the use of medication such as oestrogenic hormonal replacement therapy 21 , antidepressants 22 and antihistamines 23 . Ocular surgeries, in particular laser corneal refractive surgery, may also cause or aggravate dry eye 24 . Additionally, smoking or alcohol consumption 19, 25 , sleep apnoea 26 , time spent reading or performing computer work 27, 28 as well as time spent in air conditioned facilities 29 can worsen dry eye.
To reduce symptoms, simple changes may be suggested to dry eye patients, including lowering of computer screens to levels below the eyes thus reducing interpalpebral aperture 30 , supplementing diets with omega-3 fatty acids 28, 31 and/or using humidifiers in dry environments 1 . It may also be beneficial to recommend reducing contact lens wear and a sufficient amount of sleep of at least six to seven hours.
topical treatment for Dry Eye
In addition to the above, the mainstay first-line therapy for dry eye are topically administered lubricants 32 . The aim of tear replacement is to replenish the tear volume, stabilise the tear film, preserve the smooth refracting surface of the tear film, protect the ocular surface epithelial cells and reduce friction of the eyelids on the cornea while blinking 33 .
There are a wide range of over-the-counter artificial tear substitutes and prescription drugs, such as topical cyclosporine and topical steroids 34 . However, it is not advisable for healthcare professionals who are not equipped to monitor the adverse effects of steroids, for example increased intraocular pressure, to prescribe steroids 35 .
Commercially available tear lubricants differ in their composition and hence vary in terms of viscosity and duration of action, presence and type of preservatives, osmolarity/ osmolality and pH 36 .
Viscosity Hydrogels, the main ingredient of artificial tears, are polymers that have the ability to retain water 37 . Examples of these include hydroxypropyl methylcellulose (HPMC), carboxy methylcellulose (CMC), polyvinyl alcohol (PVA), carbopol, polyvinyl pyrrolidone, polyethylene glycol, dextran, hyaluronic acid, or carbomer 940 (polyacrylic acid) 37 . These polymers may increase, to some extent, the viscous nature of lubricants and may possibly facilitate adhesion to the mucus layer of the tears, but none of these appear to be superior over another 37 . Hyaluronic acid, a naturally occurring glycosaminoglycan found in preparations such as BLNK® or Hialid® has been shown to benefit wound healing processes 38 . Hydroxypropyl Guar, a unique hydrogel exists in the bottle as monomers in a borate containing solution. When pH changes occur, such as during contact with the pre-ocular tear film, Guar forms cross-linkages with the borate to create a bio-protective film (Systane®) 39 .
Less viscosity results in increased lacrimal outflow, reduced retention time 40 and a shorter duration of action which may translate into more frequent eye drop instillation. High viscosity eye drops, on the other hand, have the advantage of protecting the ocular surface longer, but unwanted visual disturbances, including aberrations and blurring, may be induced 40 . Some higher viscosity eye drops may also precipitate as crystals on eyelids and lashes 41 . Therefore, extremely viscous preparations such as ointments should be instilled at bedtime to avoid visual problems. It should be emphasised that patients may need to test different types of tear lubricants to identify the optimal formulation that can be well tolerated and is comfortable to the eye. If a patient complains about excessive blurring after instillation, a less viscous alternative may be given. For example, Liquigel, a 1.0% solution of carboxymethyl cellulose (CMC) consisting of 0.35% high-viscosity and 0.65% medium-viscosity CMCs, is less viscous than Celluvisc™, a 1.0% solution of high-viscosity CMC 41 .
Preservatives
Tear lubricants can be divided into preserved and non-preserved preparations 33 . Preservatives are added to artificial tears to increase their shelf life. Non-preserved preparations are provided in small vials that usually contain less than half a millilitre of liquid, whereas preserved preparations are dispensed in bottles.
Tear lubricants with preservatives do not require refrigeration after opening and during use 33 . Given the patient does not accidentally touch the bottle tip during eye drop instillation, which may induce contamination, the preservative allows the eye drops to be used for one month or more. However, preserved eye drops may result in preservative sensitivity, in particular when using the drops more than six times a day over prolonged periods of time 33 . Preservatives, especially Benzalkonium Chloride (BAK) and chlorobutanol have been shown to damage the corneal epithelium, cause redness, eye irritation or even dry eye symptoms [42] [43] [44] . Recently introduced preservatives, such as GenAqua™ (Sodium Perborate) 45 , Purite™ (Sodium Chlorite) 43 and Polyquad® (Polyquaternium-1) 46 are less harmful to the ocular surface compared to BAK. Purite™ has the advantage to degrade into chloride ions and water after instillation, whereas GenAqua™ is converted into oxygen and water upon contact with the tear film 45 .
Non-preserved preparations carry the risk of microbial contamination and eye drops should be discarded after 24 hours of use, even though the vial can be capped or resealed after opening. However, preservative-free eye drops may be more expensive compared to preserved eye drops, especially when one requires only one to three instillations daily. Therefore, we recommend these for patients requiring frequent instillation of eye drops.
Osmolarity/Osmolality
Osmolarity is a measure of the amount of solutes in one litre of solution, and this differs in different lubricants 33 . A measure of solute concentration in tears is called tear osmolality. Increase in tear osmolality may be a key factor in the induction of dry eye, a trigger of ocular surface epithelial damage 1 , and has therefore been suggested to serve an ideal diagnostic measure 47, 48 . Furthermore, increased osmolality has been measured in tears from patients with contact-lens related dry eye 20 .
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It would be logical to suggest that hypo-osmolar eye drops (such as TheraTears®) may decrease tear film osmolarity. The results of trials with such drops show differing results [49] [50] [51] [52] and there is evidence to show that eye drops only transiently change tear osmolarity 53 .
pH Tear lubricants are electrolyte solutions that consist of different buffers and therefore different acidity 33 . We performed measurements of the pH levels of various over-the-counter lubricant preparations as presented in Table 1 . A previous study has shown that the pH of any particular formulation is stable for up to 60 days 54 . In our investigation and in a previous report by Lopez-Alemany et al 55 , it was apparent that artificial tear preparations have a wide range of pH. The tear pH levels range from 6.9 ± 0.2 56 to 7.5 ± 0.2 57 in the normal population, but this was not altered in patients with dry eye 58 . Differences of tear pH may be related to factors including carbon dioxide saturation and the presence of meibomian lipids 56 . Patients may experience a stinging sensation shortly after eye drop use, when there is a mismatch between the acidity of the instilled eye drops and the tear film 33 . This adverse effect may be responsible for the patient's disappointment with the treatment and reluctance to comply with the medication. Unfortunately, it seems unavoidable that patients need to try various tear lubricants in order to identify the most comfortable solution that matches the pH of the tear film. If a patient complains of stinging or burning after eye drop instillation, an alternative tear lubricant with a different pH may be recommended (see Table  1 showing product profiles of various dry eye lubricants).
The individual tear film pH may not be constant when measured at different time points of the same day, with more acidic pH noted after prolonged eye closure 59 . In addition, contact lens wear has been shown to significantly reduce the pH of the tear film, but normal levels are restored after contact lens removal 56 . This suggests that some patients may need to be equipped with lubricants of different pH depending on their lifestyle. Acidity of lubricants is not the only factor that may cause unpleasant sensations. The prescription medication Restasis® eye emulsion for the treatment of dry eye may also cause burning or stinging during instillation, especially in, but not limited to, the first month of use 60 .This symptom may disappear with the continuing use of Restasis®, but some patients may dislike the discomfort to the extent that they refuse to further use this medication.
Lipids
Improvement of tear lipid layer thickness can be achieved with castor oil emulsion (Endura® or Restasis® emulsion of cyclosporine 0.05%) 61 . Other lipid containing eye drops are also available.
Limitations of Lubricant Treatment
Many people are unhappy about the transient relief provided by their tear lubricants, regardless of their polymer composition 62 . Artificial tears cannot completely substitute the complex composition of natural tears, which may be anti-inflammatory 34 . For example, the well structured tear film layers, consisting of lipid, aqueous, and mucin, cannot be reproduced by artificial tears 1 . Primary tear proteins in the aqueous layer of the tear film, such as lysozyme, lactoferrin, immunoglobulin-A, and lipid binding proteins 63 , are not present in tear lubricants.
some recommendations on the Use of tear Lubricants
There is a large variety of commercially available lubricants and it may not be easy to select the one most beneficial for the individual dry eye patient. The general principle is that a greater severity of dry eye requires more viscous lubricants and more frequent instillation. Trial and error may be necessary to find the optimal regime and viscosity. A different degree of viscosity of tear substitutes may be chosen during the course of a day, for example, less viscous eye drops during the day and a highly viscous ointment at night. Patients who are afraid to instill lubricants should be reassured. The patient's needs should be considered, and the most suitable dosage identified according to their requirements. For instance, the dosage may be increased, if the patient anticipates working for long hours on the computer or driving at night.
Factors Affecting Patients' Compliance
As dry eye is a chronic disease, tear lubrication is required for the long-term. Dry eye patients who are recommended to regularly use tear lubricants, often discontinue 64 . Low compliance or poor acceptance of these medications may have several reasons including complicated regimens, high frequency of dosage, adverse effects and high cost of tear substitutes 65 . Other contributing patient factors include poor memory, mild disease as well as lack of understanding of the aim and rationale of the treatment. The patient may feel that the prescribed tear lubricants do not improve dry eye conditions effectively which often lead to reduced acceptance and compliance of the prescribed regimen 64 . Often patients rely on the support of their family to implement daily treatment routines, but if this is not given, the patient may not be able to comply. On the other hand, the treatment regimen may not have been explained in detail to the patient. This then may lead to a lack of understanding by the patient, causing great dissatisfaction with the treatment and subsequent discontinuation of the treatment 65 .
To improve the understanding and attitude of the patient towards the disease, an in-depth patient education of the treatment, specific agent and dosage by the prescribing healthcare professional is crucial to effectively maximise compliance and success rate of the dry eye treatment 64 .
cONcLUsION Assessment and subsequent management of dry eye may be a satisfying endeavour for any healthcare professional other than ophthalmologists. With this report, we aimed to provide an overview of available treatments and their limitations. It is important for healthcare professionals to understand the available pharmacology of tear lubricants which in turn helps to facilitate counselling of dry eye patients and selection of the appropriate treatment. We believe that patient education is a key factor to improved compliance rates. Patients need to know that the dry eye condition can often only be controlled rather than cured and so develop realistic expectations from the treatment. 
